Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy

Published:2014-02-14 Issue:4 Volume:165 Page:497-503
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Coutre Steven E.¹,Othus Megan²,Powell Bayard³,Willman Cheryl L.⁴,Stock Wendy⁵,Paietta Elisabeth⁶,Levitan Denise³,Wetzler Meir⁷,Attar Eyal C.⁸,Altman Jessica K.⁹,Gore Steven D.¹⁰,Maher Tracy²,Kopecky Kenneth J.²,Tallman Martin S.¹¹,Larson Richard A.⁵,Appelbaum Frederick R.¹²

Affiliation:

1. Stanford University School of Medicine; Stanford CA USA

2. SWOG Statistical Center; Seattle WA USA

3. Wake Forest University School of Medicine; Wake Forest NC USA

4. University of New Mexico Cancer Center; Albuquerque NM USA

5. University of Chicago; Chicago IL USA

6. Montefiore Medical Center; North Division, Bronx NY USA

7. Roswell Park Cancer Institute; Buffalo NY

8. Massachusetts General Hospital; Boston MA USA

9. Northwestern University; Chicago IL USA

10. Johns Hopkins University; Baltimore MD USA

11. Memorial Sloan Kettering Cancer Center; New York NY USA

12. Fred Hutchinson Cancer Research Center; Seattle WA USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12775/fullpdf

Reference18 articles.

1. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience;Ades;Blood,2010

2. A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study;Asou;Blood,2007

3. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance;Avvisati;Blood,2011

4. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group;Fenaux;Blood,1999

5. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL);Gupta;Leukemia Research,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy;Hematology, Transfusion and Cell Therapy;2024-05

2. Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen;Clinical Trials;2023-10-25

3. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG;Hematology;2023-03-23

4. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions;Frontiers in Oncology;2023-01-18

5. Childhood Acute Promyelocytic Leukemia;Reference Module in Biomedical Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3